BridgeBio Pharma, Inc. (BBIO)

Market Closed

16 Oct, 08:00 PM

NASDAQ (NGS)

66. 39

-0.74

-1.1023%

13.14B Market Cap

- P/E Ratio

- Div Yield

2.06M Volume

-3.85 Eps

$ 67.13

Previous Close

Investors:

Analysts:

Day Range

65.26 67.04

Year Range

52.75 93.42

Want to track BBIO and more in your Portfolio? 🎯

BridgeBio Pharma, Inc. Investors

Name	Quantity	Cost	Value	Profit ($)	Gain (%)
EG Ethan Gilbert Rialto Wealth Management LLC	18	$1,015.58	$1,208.34	$192.76	18.98%
Yuen Man Lee Persistent Asset Partners Ltd.	526	$39,060.77	$34,702.85	-$4,357.92	-11.16%
Rossby Financial LLC Rossby Financial LLC	10	$745	$671.3	-$73.7	-9.89%
WJ William Jones TEMA ETFs LLC	76,076	$3.49M	$5.05M	$1.56M	44.71%
DWM Dogwood Wealth Management LLC Dogwood Wealth Management LLC	57	$4,252.56	$3,792.21	-$460.35	-10.83%
GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.	4,103	$144,172.97	$270,798	$126,625.03	87.83%
JCB John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH	96,883	$4.4M	$6.5M	$2.1M	47.67%
David R. Hess Wealth Management Associates Inc.	10,754	$426,890.05	$707,021.73	$280,131.68	65.62%
Nicole Reese WPG Advisers LLC	115	$8,787.48	$7,719.95	-$1,067.53	-12.15%
HFM Investment Advisors LLC HFM Investment Advisors LLC	16	$884.83	$1,079.54	$194.71	22.01%
AS Aryn Sands GK Wealth Management LLC	114	$7,501	$7,403.16	-$97.84	-1.3%